1.95 0.02 (1.04%)

63.07% Fall from 52W High

17,731 XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Intensity Therapeutics Inc

The latest disclosure was made by Joseph Talamo in Intensity Therapeutics Inc where a trade of 427,379 Stock Option (right to buy Common Stock) done was reported to US exchanges on Oct. 21, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Joseph Talamo Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 427,379 427,379 - - Stock Option (right to buy Common Stock)
John Wesolowski Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 70,028 70,028 - - Stock Option (right to buy Common Stock)
John Wesolowski Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2024 1,000 14,000 - - Stock Option (right to buy Common Stock)
John Wesolowski Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. 05 Jun 2024 1,000 6,691 - 4 4,000 Common Stock, $0.0001 Par Value
Thomas I.H. Dubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2024 50,000 50,000 - - Stock Option (right to buy Common Stock)
Lewis H. Bender Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 464,805 464,805 - - Stock Option (right to buy Common Stock)
Lewis H. Bender Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 33,574 33,574 - - Stock Option (right to buy Common Stock)
Emer Leahy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 50,000 50,000 - - Stock Option (right to buy Common Stock)
John Wesolowski See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 25,000 25,000 - - Stock Option (right to buy Common Stock)
Joseph Talamo Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2023 80,000 80,000 - - Stock Option (right to buy Common Stock)
John Wesolowski Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 50,000 50,000 - - Stock Option (right to buy Common Stock)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures